Teva Announces FDA Approval, Commercial Launch of Generic Flomax Capsules

Teva Pharmaceutical Industries Ltd. announced U.S. Food and Drug Administration approval and commercial launch of its generic version of Boehringer Ingelheim’s Flomax, or tamsulosin hydrochloridem, Capsules, 0.4 mg, a product indicated for the treatment of signs and symptoms of benign prostatic hyperplasia.
RTTNews